H.R. 9149: National Diabetes Project Act

This legislation, known as the National Diabetes Project Act, establishes a national initiative aimed at addressing diabetes in the United States. The main components of the bill include the following:

Establishment of the National Diabetes Project

A program will be set up within the Office of the Secretary of Health and Human Services (HHS) dedicated to diabetes management. This project will work to:

• Create and maintain a national plan to combat diabetes.
• Coordinate and supply information related to diabetes research and services across various federal agencies.
• Accelerate the improvement of treatments that could prevent, stop, or reverse diabetes.
• Enhance the early diagnosis of diabetes and improve how care is coordinated for those with the condition.
• Ensure that at-risk ethnic and racial groups receive adequate care and that efforts to reduce health disparities are made.
• Collaborate with international organizations to assist in the global fight against diabetes.

Duties of the Secretary of Health and Human Services

The Secretary of HHS will oversee the development and regular updating of the national diabetes plan. This includes:

• Conducting annual assessments of the nation’s strategy to cope with the rising diabetes burden.
• Evaluating all federal diabetes programs and their budgetary considerations.

Advisory Council on Diabetes Research, Care, and Services

An advisory council will be created, comprising both federal and non-federal members, tasked with guiding the Secretary on various matters related to diabetes. The council will:

• Include experts from different fields such as healthcare, diabetes advocacy, and state health departments.
• Meet quarterly and provide public access to their meetings.
• Submit an annual report to the Secretary and Congress on federal efforts in diabetes management, evaluations, and recommendations for priority actions.

Data Sharing Requirements

Federal agencies that collect diabetes-related data will be required to share this information with the Secretary of HHS to support the national project and facilitate comprehensive reporting.

Annual Reporting Obligations

The Secretary of HHS must produce an annual report that evaluates all federally funded diabetes initiatives, including:

• Performance assessments of programs related to diabetes.
• Recommendations for action to reduce financial burdens on federal healthcare programs and families dealing with diabetes.
• Strategies to improve health outcomes for individuals with diabetes.
• Updates to the national plan as necessary.

Expiration Clause

The National Diabetes Project will be set to expire on December 31, 2036, unless further action is taken to extend it.

Relevant Companies

• NVO - Novo Nordisk: A major pharmaceutical company involved in diabetes care through insulin and GLP-1 receptor agonists.
• AMGN - Amgen: Engaged in the development of therapies for diabetes among other chronic conditions.
• SNY - Sanofi: Another significant player in diabetes treatments, particularly insulin products.
• PRGO - Perrigo: Focuses on over-the-counter diabetes care products, potentially influenced by new regulations and initiatives.